HIV Prevalence Among Drug Users in China
Author Information
Author(s): Mirjam Kretzschmar, Weidong Zhang, Rafael T Mikolajczyk, Lan Wang, Xinhua Sun, Alexander Kraemer, Fan Lv
Primary Institution: School of Public Health, University of Bielefeld, Bielefeld, Germany
Hypothesis
Are there regional differences in HIV prevalence among drug users in China that could indicate potential for future spread of HIV?
Conclusion
Regional differences in HIV prevalence in China reflect different stages of the drug use and HIV epidemics rather than differences in risk behaviours.
Supporting Evidence
- The overall HIV-1 antibody prevalence was 5.4% among the sample.
- Prevalence rates ranged from 0% to 54% across different surveillance sites.
- Risk behaviours were highly prevalent in regions with low HIV prevalence.
Takeaway
This study found that HIV rates vary a lot in different parts of China among drug users, and some areas are at risk of future outbreaks.
Methodology
Data was collected from 21 drug user surveillance sites across 14 provinces in China using random effects logistic regression to analyze risk factors and regional differences.
Potential Biases
The lack of a systematic sampling frame across different sites may introduce bias in the data.
Limitations
Methodological limitations of surveillance embedded into routine systems limit the usability of existing data.
Participant Demographics
The sample was predominantly male with a male-to-female ratio of 5.6:1, ages ranged from 14 to 78 years, with a median age of 30.
Statistical Information
P-Value
0.002
Confidence Interval
95% CI
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website